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Abstract
Background—Binge-drinking is common in human adolescents. The adolescent brain is
undergoing structural maturation and has a unique sensitivity to alcohol neurotoxicity. Therefore,
adolescent binge ethanol may have long-term effects on the adult brain that alter brain structure
and behaviors that are relevant to alcohol use disorders.
Methods—In order to determine if adolescent ethanol binge drinking alters the adult brain, male
C57BL/6 mice were treated with either water or ethanol during adolescence (5g/kg/day i.g., post-
natal days P28-37) and assessed during adulthood (P60-P88). An array of neurotransmitter-
specific genes, behavioral tests (i.e. reversal learning, prepulse inhibition, and open field), and
post-mortem brain structure using MRI and immunohistochemistry, were employed to assess
persistent alterations in adult brain.
Results—At P38, 24 hours after adolescent ethanol (AE) binge, many neurotransmitter genes,
particularly cholinergic and dopaminergic, were reduced by ethanol treatment. Interestingly,
dopamine receptor type 4 mRNA was reduced and confirmed using immunohistochemistry.
Normal control maturation (P38-P88) resulted in decreased neurotransmitter mRNA, e.g. an
average decrease of 56%. Following adolescent ethanol treatment, adults showed greater gene
expression reductions than controls, averaging 73%. Adult spatial learning assessed in the Morris
water maze was not changed by adolescent ethanol treatment, but reversal learning experiments
revealed deficits. Assessment of adult brain region volumes using MRI indicated that the olfactory
bulb and basal forebrain were smaller in adults following adolescent ethanol.
Immunohistochemical analyses found reduced basal forebrain area and fewer basal forebrain
cholinergic neurons.
Conclusions—Adolescent binge ethanol treatment reduces adult neurotransmitter gene
expression, particularly cholinergic genes, reduces basal forebrain and olfactory bulb volumes,
and causes a reduction in the density of basal forebrain acetylcholine neurons. Loss of cholinergic
neurons and forebrain structure could underlie adult reversal learning deficits following adolescent
binge drinking.
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Introduction
Adolescence is best defined by characteristic behaviors including high social interaction and
play behavior, high levels of risk-taking, high activity and exploration, impulsivity, and
novelty and sensation seeking (Ernst et al., 2009; Spear, 2000). Adolescent behaviors are
shared across many species, from humans (12 to 20–25 years of age) to mice (post-natal
days 28 to 42) and others (Spear, 2000). Recent studies indicate that adolescent brain
structural development coincides with consolidation of adult abilities (Blakemore and
Choudhury, 2006), including intelligence (Shaw et al., 2006) and behavioral control of
executive functions (Ernst et al., 2009). Adolescent brain maturation involves peaks in
cholinergic, dopaminergic, and serotoninergic inputs to frontal cortex, as well as cortical
width peaking during adolescence and then declining to stable adult levels (Giedd, 2004;
Giedd et al., 2008; Gould et al., 1991; Kalsbeek et al., 1988; Kostovic, 1990; Rosenberg and
Lewis, 1994; Spear, 2000). Developing systems are sensitive to ethanol neurotoxicity. Rat
models of adolescent binge drinking find significant frontal neurodegeneration (Crews et al.,
2000a) and loss of neurogenesis (Crews et al., 2006), suggesting that the adolescent brain is
uniquely sensitive to ethanol neurotoxicity (Crews et al., 2007).
Current statistics indicate alcohol consumption during adolescence is common, with
approximately 12% of 8th graders, 22% of 10th graders and 28% of 12th grade seniors
reporting heavy episodic drinking (more than 5 drinks in a row) within the past 2 weeks of
survey (Johnston et al., 2004; Masten et al., 2008). Heavy drinking increases among college
students, 44% report binge drinking every 2 weeks and 19% report more than 3 binge-
drinking episodes per week (O'Malley et al., 1998; Wechsler et al., 1995). Adolescents have
low sedative responses to alcohol, enabling them to consume higher quantities of alcohol,
leading to high blood alcohol levels (Silveri and Spear, 1998). Adolescents with alcohol use
disorder average 14 drinks per occasion (Deas et al., 2000). The lifetime prevalence of past-
year alcohol dependence peaks at 12% between the ages of 18 and 20, and declines across
adulthood (Masten et al., 2008). The numerous changes in brain structure coupled with the
high levels of alcohol consumption provide a strong rationale to conduct basic studies to
understand the impact of underage drinking over the lifespan.
We utilized a mouse model of adolescent binge drinking to better understand adolescent
brain development and the impact of binge drinking. C57BL/6 mice were evaluated both
just after ethanol treatment towards the end of adolescence (P38) and weeks after treatment
during young adulthood. Among subtypes of alcohol dependence, adolescent-youth limited
adult alcohol dependence is the most common subtype (Jacob et al., 2005; Moss et al.,
2008). We found that adolescent binge treatment altered adult gene expression, particularly
cholinergic genes, reduced olfactory bulb and forebrain volume, decreased cholinergic
neuron density and caused deficits in reversal, but not spatial learning.
Methods
Animal treatment
Male C57BL/6 mice were used for this study. Mice were ordered from Charles River Labs
(Raleigh, NC), and were allowed to acclimate to the animal facilities for seven days in our
animal facility prior to treatment. Adolescent mice were requested with the stipulation that
all mice were the same weight, in order to reduce potential variability in brain size, and
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arrived on P21. At P28, animals were divided into control and ethanol treatment groups with
five mice per cage. Prior to behavioral testing, 2-3 mice were housed per cage and given one
week to acclimate prior to testing.
Mice were treated and tested as shown in Figure 1. Groups of mice were treated during
adolescence (P28-37; Figure) and during adulthood (P88-97, Figure 1). Mice were given
either water or ethanol (5g/kg, 25% ethanol w/v) intragastrically once per day for 10 days.
Adolescent ethanol (AE) treatment resulted in an average blood alcohol level of 287.7 mg/
dL ± 36.8 (mean±SEM) measured 1 hour after the last ethanol administration. This is similar
to blood alcohol levels that we have observed previously in young adult mice (P56-65)
treated with ethanol (5 g/kg/day i.g), where we observe blood alcohol levels of 316 mg/dL ±
11 (Qin et al., 2008). Binge ethanol treatment caused a delay in the adolescent growth spurt.
In control mice, an increase in weight occurred from P28 to P32 (15.8 g to 17.5 g, 11%)
followed by a plateau in weight from P32-P36 and another increase in weight from P36 to
P49 (3.5 g, 19% increase) (Supplemental Figure 1). Mice that received the ethanol binge
during adolescence were different from controls in that they did not experience a weight
gain until P36, causing the average weight of ethanol treated mice to be significantly less
than controls from P32 to P36 (Supplemental Figure 1; *p<0.05 ANOVA with Bonferroni
post-tests). By P42, ethanol treated mice recovered and underwent a greater weight gain than
controls from P36 to P49 (4.73 g, 31% increase) to arrive at weights by P49 that were not
significantly different (Control: 21.7 ± 0.4, Ethanol: 20.23 ± 0.4, p>0.05).
For neurotransmitter receptor gene array studies, mice were sacrificed by perfusion with
saline either 24 hours (N=6 control, 6 ethanol) or 50 days (N=5 control, 5 ethanol) following
AE treatment (Figure 1). Similarly, a group of young adult mice (P88) underwent a ten day
treatment as adults (P88-97) and were assessed either 24 hours (N=6 control, 6 ethanol) or
50 days (N=5 control, 6 ethanol) after binge ethanol (Figure 1). A third group of mice that
received adolescent binge ethanol treatment underwent behavioral testing in adulthood
(P60-72) and were sacrificed one week after the end of behavioral testing for postmortem
brain magnetic resonance imaging (MRI) and immunohistochemistry (IHC) (Figure 1, N=10
control, 8 ethanol). All protocols were approved by the University of North Carolina
Institutional Animal Care and Use Committee and were ins accordance with the
Congressional Animal Welfare Act.
Perfusion and brain tissue preparation for MRI and IHC
For MRI and IHC studies, mice were first anesthetized with pentobarbital (100mg/kg, i.p.)
and then sacrificed by perfusion as described previously (Coleman et al., 2009; Crews et al.,
2004). Briefly, mice were perfused with 0.1M phosphate buffered saline (PBS) followed by
4% PFA followed by post-fixation in 4% PFA at 4°C for 24 hours. The ears and skin were
then removed from the head and the skull was re-immersed in 4% PFA for 24 hours. Mouse
skulls with the brains intact were then submerged in a 1% PFA/PBS solution at 4°C until
MRI. To ensure that time between imaging did not alter brain volume; four postmortem
adult mice were scanned twice with each scan being three months apart. Importantly, there
was no significant difference in total brain volume across this 3 month time period in these
mice (t-test, p=0.62). Neither did we observe a correlation between brain volume and scan
date (R= −0.0017, p=0.994).
Neurotransmitter receptor and regulator gene quantitative real-time PCR array
Mice were treated either during adolescence or adulthood for neurotransmitter receptor and
regulator gene expression analysis (Figure1). Messenger RNA was extracted from whole
brain using Trizol reagent, followed by purification with RNeasy column (Qiagen, Valencia,
CA). The total RNA was converted into first stranded-cDNA using an RT first strand kit
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(SAB Bioscience Corporation, Frederick, MD). DNAase treatment was included in the kit to
ensure the removal of genomic DNA. Quantitative real-time PCR was performed using a
Bio-rad MyiQ Single-Color RT PCR Detection System. The Mouse Neurotransmitter
Receptors and Regulators RT2 Profiler™ PCR Array, which assesses 84 genes
(Supplemental Table 1) was used to perform the reaction (SABioscience Corporation;
PAMM-060). The Sybr green DNA Real-Time PCR Mix was purchased from Applied
Biosystems (Foster City, CA). The PCR mix was denatured at 95°C for 10 min before the
first PCR cycle. The thermal cycle profile was programmed for denaturation for 15 s at 95°C
and annealing for 60 s at 60°C. A total of 40 PCR cycles were performed. Data analysis was
performed using the ΔCt method using the Data Analysis Template Excel file provided by
SABioscience Corporation as published previously (Lee et al., 2008). Values for ΔCt were
normalized to the average of five housekeeping genes: glucuronidase β, hypoxanthine
guanine phosphoribosyl tranferase1, heat shock protein 90kDa α class b member 1,
glyceraldehydes-3-phosphate dehydrogenase, and β actin. As recommended by
SABioscience, a 2-Way ANOVA with Bonferroni post-tests (using average ΔCt values) was
used to detect changes across the entire array as well as individual genes while accounting
for multiple comparisons to reduce the probability of type II errors. The percent of
expression relative to the adolescent control group (P38) is presented for each gene.
Adult behavioral testing: prepulse inhibition, elevated plus maze, locomotor behavior, and
Morris water maze with reversal
Behavioral testing was performed in adulthood, beginning on P60 in the following order:
P60-elevated plus maze, P61-locomotor behavior, P62-prepulse inhibition, P63-72-Morris
Water Maze with reversal learning. All behavioral tests were performed in the UNC
Neurodevelopmental Disorders Research Center Mouse Behavioral Phenotyping Core.
Elevated plus maze
The elevated plus maze was elevated 50 cm from the ground, and had two walled arms (20
cm in height) and two open arms. Animals with increased anxiety are predicted to spend less
time in the open arms. Mice underwent one five-minute trial in the elevated plus maze. The
observed measures were time on, and number of entries into, the open and closed arms.
Locomotion with center time in open field—Locomotor activity was used as a
measure of overall activity and exploratory behavior in a novel environment. Reduced
exploration was an index of anxiety-like behavior (Crawley, 1999). The open field chamber
(40 cm × 40 cm × 30 cm, VersaMax system, AccuScan Instruments) was crossed by a grid
of photobeams to detect motion. Mice were tested for one hour in the open field chamber.
Measures of distance traveled, rearing movements, and time spent in the center were taken.
Prepulse inhibition
Prepulse inhibition of the acoustic startle response was used as a measure sensorimotor
gating. Prepulse inhibition occured when a low pre-stimulus of varying intensity (20 ms
duration; 74, 78, 82, 86, and 90 dB) was given 100ms prior to a louder startle stimulus (40
ms duration; 120 dB), diminishing the response to the louder stimulus. Mice were tested
with a San Diego Instruments SR-Lab system as described previously (Moy et al., 2006;
Paylor and Crawley, 1997). The peak startle amplitude during a 65-msec period beginning
with the startle stimulus was measured. Each test session consisted of forty-two trials,
following a five-minute habituation period.
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Morris water maze spatial and reversal learning in adults
The Morris water maze task was used to test spatial learning and memory as well as the
ability to reverse a learned response as described previously (Moy et al., 2007). The water
maze (122 cm in diameter) was filled with 45 cm deep water at 24-26° C. The room had
numerous visual cues. Water in the maze was tinted white with nontoxic poster paint so the
escape platform was not visible. The experimenter was blinded as to the treatment group of
the mice. The measures taken were swimming distance, swimming velocity, and latency to
find the platform by an automated tracking system (Noldus Ethovision). In each test, mice
that displayed significant floating behavior (average swimming velocity of <10cm/s) were
removed from the analysis. Criterion for acquisition of learning was set at a 15-second
average latency of all the mice to find the platform.
Visual Cue—Mice were first tested for their ability to find the 12 cm diameter visible
platform having a tall cylinder as the visual cue. This was used to identify whether any mice
had visual or motor deficits that could prohibit them from learning the hidden platform
tasks. Mice were given four trials per day until criterion was achieved. Each mouse was
placed in the pool at one of four possible randomly ordered locations, and then given 60
seconds to find the cued visible platform.
Initial Learning Acquisition—Mice were evaluated in the hidden platform task using the
same procedure as described above. The platform was submerged under the water in
Quadrant 1. C57BL/6 mice have been found to acquire learning by day six of testing (Moy
et al., 2007). Mice were given four trials per day to learn the position of the hidden platform.
Once the 15 second criterion was reached for the entire group, mice were given a one-
minute probe trial in the pool without the platform in place. During the probe trial, the time
spent in each quadrant of the pool was measured.
Reversal Learning—Mice were then tested for their ability to ‘unlearn’ the previous
location of the platform and to learn its new location. The location of the hidden platform
was moved to the opposite quadrant of the water maze (Quadrant 3), and mice were tested
for acquisition of the new location. After reaching the 15-second group-wide criterion, mice
underwent a second probe trial to assess quadrant preference after reversal. During the
reversal probe trial, normal C57/BL6 mice were shown to spend more time in the most
recent quadrant (Q3), than in the initial learning quadrant (Q1) (Moy et al., 2007). Thus,
mice with perseverative reversal learning deficits were expected to spend more time in the
former quadrant (Q1) than unimpaired mice.
Postmortem MRI and Image Segmentation
Following behavioral testing and sacrifice, whole mouse skulls with brain intact were
scanned at the UNC Biomedical Research Imaging Center (BRIC) on a 9.4 Tesla Bruker
BioSpec spectrometer (Bruker Biospin Inc., Billerica, MA). High-resolution MRI images
(0.12mm × 0.12mm × 0.12mm) were acquired using the following diffusion weighted 3D
RARE sequence: TR=0.7s, TEeff =23.662ms, Rare Factor = 3, RARE echo spacing =
11.3067ms, diffusion gradient time δ =6ms, diffusion gradient separation Δ = 12.422, b
value – 1000s/mm2, matrix size = 200×125×80, FOV=24.0mm × 15mm × 9.6mm. Total
scan time was 15 hours per animal. Each head was scanned individually.
Mean diffusivity images, which were computed from the reconstructed diffusion tensor data,
were aligned and brain structures were segmented using an automatic segmentation protocol
developed at the UNC Neuro Image Research and Analysis Laboratory (NIRAL) (Lee et al.,
2009). Following automatic segmentation, blinded investigators manually post-segmented
selected regions of interest identified from the automatic segmentation, as well as measuring
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region volume using ITK-SNAP™ software version 1.8. Brain region boundaries were
determined using the Brookhaven National Library 3-D MRI Digital Atlas Database of the
adult C57BL/6 mouse (www.bnl.gov/medical/RCIBI/mouse).
Immunohistochemistry and Image Analysis
Immunohistochemical images were captured using an Olympus BX51TRF microscope and
ProgRes® CapturePro 2.5 digital camera system (Jenoptik, Germany). The Bioquant Nova
Advanced Image Analysis System™ was used to assess histological area and neuron density
(immuno-positive neurons/mm2) using a cell counting technique described previously
(Coleman et al., 2009; Crews et al., 2004). We have shown previously that this method
results in nearly identical percent changes between treatment and control groups as other
unbiased stereological techniques (Crews et al., 2004). In order to confirm MRI volume
findings, area measurements of the basal forebrain were taken using Bioquant on sections
labeled for parvalbumin. Parvalbumin interneurons filled the nuclei of the basal forebrain,
making landmarks and boundaries more easily identifiable. Up to six sections in three
different regions, defined by distance from bregma, were measured. Anatomical landmarks
were identified using the mouse atlas (Franklin and Paxinos, 2001) in the same regions as
those analyzed by MRI. The landmarks for each bregma and the corresponding nuclei were
as follows: +1.34 to +1.1-concentric horns of the forceps minor of the corpus callosum to
the genu of the corpus callosum including the medial septum, vertical limb of diagonal band,
and ventral pallidum; +0.86 to +0.14-narrowing of the corpus callosum and appearance of
the lateral septum to the decussation of the anterior commissure which included the lateral
septal regions, medial septum, ventral pallidum, substantia innominata, horizontal diagonal
band, magnocellular preoptic, and lateral preoptic areas; +0.02 to −0.22-separation of the
anterior commissure decussation to the disappearance of the anterior commissure posterior,
using the posterior wings of the anterior commissure and the internal capsule as landmarks
in conjunction with parvalbumin staining to triangulate the basal forebrain nuclei which
included the ventral pallidum, substantia innominata, horizontal diagonal band, bed nucleus
of striatum, magnocellular preoptic nucleus, anterior amygdaloid area dorsal, and the
interstitial nucleus of the posterior limb of the anterior commissure.
To determine the density of choline acetyltranferase (ChAT) immuno-reactive (IR) neurons,
a technique using Bioquant imaging software was used by a blinded investigator with three
to six sections per mouse (Crews et al., 2004). The region of the basal forebrain that had the
greatest volumetric reduction as measured by MRI, (bregma +0.14 to −0.22) was identified
on the sections using the adult mouse atlas (Franklin and Paxinos, 2001). This has been
designated previously in rodents as the Ch4 region (Mesulam et al., 1983). Sections from
three bregma locations were analyzed (+0.14,−0.10, and −0.22). These bregma locations
were identified reliably using major landmarks in the mouse atlas (+0.14-the decussation of
the anterior commissure, −0.10 shape of the posterior region of the anterior commissure and
the triangular configuration of the fornices and dorsal third ventricle, −0.22 reduced size of
the posterior region of the anterior commissure and the third ventricle). ChAT+IR neurons
per immunohistochemical area of the region including the horizontal diagonal band,
substantia innominata, and ventral pallidum was determined. The number of ChAT+IR
neurons was counted manually using bioquant, and the area of the circumscribed region was
reported in mm2 by Bioquant. The density of ChAT+IR neurons/mm2 was averaged
between both hemispheres at each of the three distances from bregma and then averaged
across the entire region investigated (+0.14 to −0.22).
Statistical Analysis
Gene array statistical analysis—In order to analyze the Superarray data, the company
recommended using a 2-way ANOVA with average ΔCt values followed by Bonferroni
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post-tests to identify statistically significant changes of individual genes while accounting
for the multiple comparisons. To gain additional insight, simple t-tests of normalized ΔCt
values were also performed on each gene using the company's spreadsheet, in order to
identify candidate genes that may not reach statistical significance following the stricter
Bonferroni method. The t-test analyses may result in type II errors resulting in false
positives due to the multiple comparisons, but these statistics are presented in order to more
completely identify candidate genes. Values in groups that received treatment during
adolescence (i.e. P38 ethanol group, P88 control group, and P88 ethanol group) were
compared to the P38 control group (Figure 1). Similarly, groups that underwent adult
treatment (i.e. P98 ethanol group, P148 control, and P148 ethanol) were compared to the
P98 control group.
Structural MRI Image statistics—For the automatic segmentation volume data, simple
t-tests were performed to identify candidate regions for further manual segmentation
(p<0.05). Following manual correction, t-tests performed and corrected corrected for
multiple comparisons using the Bonferroni method using the following formula: p<0.05/4
comparisons. Therefore a p<0.0125 was required to be considered statistically significant.
Behavioral and Immunohistochemistry statistics—A Student's t-test or two-Way
ANOVA were used for most behavioral and immunohistochemical comparisons (p<0.05 for
significance). For prepulse inhibition and locomotor activity, a repeated measures 2-way
ANOVA was used.
Results
Decreased Neurotransmitter-Specific Gene Expression During Adolescent Brain
Maturation and Binge Ethanol Treatment
Synaptic connections increase during brain development, reaching a developmental peak
associated with high levels of plasticity that mature to lower stable adults levels. To
investigate broad changes in neurotransmitter gene expression during adolescent brain
maturation to young adulthood (P38 - P88), we used an RT-PCR Superarray™ of 84
neurotransmitter-specific mRNAs. Eleven genes were removed from the analysis due to
insufficient yield (Table S1). Interestingly, there was a significant main effect of age on the
expression of neurotransmitter-specific genes in controls across the entire array from P38 to
P88(Figure 2A; average reduction of 56%, p<0.0001, F=282.4). The expression of thirty-
five mRNAs was lower in P88 young adults as compared to P38 adolescents (Table 1; t-test,
*p<0.05, **p<0.01, § p<0.05 Bonferroni post-test). Only six of the 73 neurotransmitter-
specific mRNA did not decline between P38 and P88 (See Figure 2A). Adolescent brain
maturation showed large decreases in peptide, γ-amino-butyric acid (GABA), cholinergic
and dopaminergic gene expression (Fig. 3,Fig. 4 and Table 1). Examples include peptides
such as NPY and somatostatin receptors, which decreased 70-80% during brain maturation
across receptor subtypes (Table 1). These peptides are often found in inhibitory GABAergic
interneurons. Between P38 and P88, GABAA receptor subunit mRNA and the GABA
synthetic enzyme, glutamate decarboxylase, decreased 70-80%. Also, acetylcholine receptor
mRNA, both muscarinic and nicotinic, and the acetylcholine synthetic enzyme ChAT
decreased approximately 60-80% during adolescent brain maturation (Table 1), although
acetylcholinesterase (Ache), the acetylcholine inactivating enzyme, maintained a constant
level of expression during adolescent brain development (Figure 2A). A reduction in
neurotransmitter mRNA expression between adolescence and young adulthood is consistent
with maturation of neurocircuitry.
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To compare maturation changes in gene expression across adolescent to young adulthood
(P38-P88) to a similar period, (i.e., 50 days across young adulthood), we also investigated
neurotransmitter gene changes between P98 to P148. There was a significant main effect of
age on gene expression between P98 and P148 (Figure 2B; average reduction of 33%, 2-
Way ANOVA: p<0.0001, F=109.8). Using t-tests, 11 genes showed continuing
developmental reductions, mostly peptide receptors, muscarinic cholinergic receptors and
GABAA subunits (Table 2, Figure 2B; t-test *p<0.05), with four genes reaching statistical
significance following Bonferroni post-tests: GABAR α4, GAD1, Galantin receptor 1,
Prokineticin receptor 2, and Neuropeptide FF receptor 2 (Table 2). Linear plots of gene
expression show different patterns of gene expression across all the genes in the array during
the two different developmental time periods (Figure 2A and 2B). Following adolescent
control treatment, adolescent maturation (P38-P88) shows a dark band of many genes with
reductions greater than 60% (Figure 2A; overall average reduction of 56%), whereas young
adult maturation (P98-P148) shows less robust declines (Figure 2B; overall average
reduction of 33%).
Neurotransmitter-specific gene expression allows for a global assessment of the impact of
ethanol on the brain. The impact of the ethanol binge drinking procedure was assessed in
both adolescent and young adult groups one day after treatment and 50 days later. There was
a significant main effect of AE binge treatment (P28-37, Figure 1A) on neurotransmitter-
specific gene expression 24 hours after treatment on P38 (Figure 2C; average reduction of
57%, p<0.0001, F=161.2). However, there was not a significant main effect of binge ethanol
treatment during adulthood (P88-97) on neurotransmitter-specific gene expression 24 hours
after treatment (Figure 2D; p = 0.39, F=0.74). AE binge enhanced the developmental
downregulation of neurotransmitter-specific genes. A significant main effect of AE
treatment was observed (p<0.0001, F=650.9), with a larger percent reduction than controls
(73% reduction vs. 57% in controls). Of the 73 neurotransmitter-specific genes measured in
the array, 58 were persistently reduced by binge ethanol treatment at P88 (Table 1, *p<0.05,
**p<0.01 t-test, P38 control vs P88 ethanol), and 31 after Bonferroni correction for multiple
comparisons (Table 1, §p<0.05 Bonferroni post-test). Regarding the 15 cholinergic genes,
expression in young adult controls (P88) averaged 37% (range 23-75%) of control
adolescent (P38) levels with no single gene significantly decreased (Table 1). AE binge
treatment significantly altered cholinergic genes. Cholinergic gene expression in young
adults (P88) that received AE binge averaged 20% (range 14-45%) of control P38 levels,
with 11 of the 15 cholinergic genes showing significant reductions (Table 1, §p<0.05
Bonferroni post-test). Adults (P148) 50 days following an earlier adulthood ethanol binge
(P88-P97, Figure 1) also showed signs of an enhanced reduction in neurotransmitter-specific
gene expression (Table 2; p<0.0001, F=40.18). However, the reduction was much less than
that found in the adolescent binge treated group (average reduction of 37% vs 73%
reduction following AE binge). Also, only two individual genes were suppressed
persistently at P148 following young adult binge ethanol treatment (P88-P97): CCKα and
Galantin receptor 2 (Table 2; 56% and 55% reduction respectively, *p<0.05 t-test). The
statistical significance of these two reductions was lost after Bonferroni correction for
multiple comparisons (Table 2). These findings indicate that adolescent binge ethanol
treatment causes more pronounced and persistent decreases in brain neurotransmitter-
specific gene expression than young adult binge ethanol treatment.
Expression levels of most neurotransmitter-specific genes declined during late adolescence
to early adulthood (P38-P88), with AE binge treatment enhancing this developmental
downregulation. Interestingly, AE treatment altered the developmental trajectories of
different genes in different patterns, suggesting unique responses of each gene (Fig. 3(r),
Fig. 4). Dopamine receptor 4 (D4DR) mRNA was decreased about 71% on P38 following
adolescent binge treatment (Fig. 3, Table 1, *p<0.05, t-test of normalized ΔCt values).
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Interestingly, D4DR underwent a 70% developmental decline between P38 and P88,
whereas binge ethanol treated animals showed no additional developmental reduction, i.e.
expression on P38 and P88 following binge ethanol treatment were both 70% below P38
control levels (Table 1, Fig. 3). Since dopamine circuitry continues to develop during
adolescence in frontal cortex we used immunohistochemistry (IHC) to assess D4DR
expression. The orbitofrontal cortex (OFC) of adolescent rats showed strong punctate D4DR
+IR that was 44% less in the OFC of P38 binge ethanol treated mice compared to P38
adolescent control mice (Figure 3, *p<0.05). Since the developmental decrease in D4DR
mRNA mimicked the AE induced decrease and no developmental change occurred in
ethanol treated animals, D4DR gene expression was similar in P88 controls and P88 ethanol
treated animals (Figure 3A). Both punctate and somatic D4DR+IR staining were observed in
adults, suggesting developmental regulation of D4DR subcellular localization (Figure 3).
There was no effect of adult ethanol binge treatment (P88-P97) on D4DR gene expression
either immediately (P98) or after 50 days (P148). Thus, D4DR development is disrupted by
adolescent binge ethanol treatment, although expression levels in adults appear normal.
Other patterns of AE-induced neurotransmitter-specific gene responses involve persistent
changes in adulthood, but varied adolescent brain responses (Fig. 4, Table 1). Although AE
decreased expression in general, gene specific reductions in expression levels were often not
statistically significant at P38. Following ethanol treatment, most genes followed a
decreasing developmental trajectory similar to that found in controls (Fig. 4 and Table 1).
Gastrin releasing peptide receptor, Grpr, was unique among the transmitter genes studied, in
that its expression did not change during adolescence/early adulthood (P38-P88) or during
adulthood (P98-P148) (Figure 2). Neither was Grpr expression altered 24 hours following
adolescent binge ethanol, or at all (24h or 50 days) following adult binge ethanol treatment
(Tables 1 and 2). However, in adults (P88) 50 days after AE binge treatment, Grpr
expression was 55% of P88 controls (†p<0.05, t-test, P88 control vs P88 ethanol group),
suggesting a unique adolescent-specific ethanol effect. Other mRNAs that were not
markedly altered on P38 just after AE binge treatment, but showed statistically significant
reductions 50 days after AE treatment (P88) were cholecystokinin α and β (CCKα and
CCKβ), and the glycine receptor α1 subunit (†p<0.05, t-test of normalized ΔCt values, P88
control vs P88 ethanol group). The pattern of developmental expression for these genes is
illustrated by the peptide receptor CCKβ (Figure 4). AE binge ethanol caused a 45%
decrease in CCKβR mRNA 24 hours after the end of the binge. Control animals underwent
a 55% reduction in CCKβR mRNA from P38 to P88 (*p<0.05) while, ethanol treated
animals underwent an additional 37% reduction in gene expression from P38 to P88,
resulting in an overall 82% significant reduction from P38 control levels (§ p<0.05
Bonferroni post-test vs P38 control, †p<0.05 t-test vs P88 control). Catechol-O-
methyltransferase (COMT) showed a particularly interesting pattern of altered
developmental trajectory (Figure 4). Adolescent binge ethanol did not cause any change
COMT gene expression at P38. Although there was a non-significant developmental
reduction in controls (29% reduction, p=0.24), adolescent binge treatment resulted in a 64%
significant decrease in COMT mRNA expression in P88 adults (Table 1, Fig 4 **p<0.01 t-
test). Similar developmental effects were observed with two other genes associated with the
dopaminergic system, dopamine receptors D1a and D2. Thus, although alcohol showed no
immediate effect on COMT, dopamine D1a or D2 expression, the developmental trajectories
were altered resulting in persistent reduced expression in adults. Therefore, adolescent binge
ethanol treatment alters neurotransmitter-specific gene developmental trajectories,
contributing to persistent changes in adult neurotransmitter gene expression.
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Young Adult Behavior Following Adolescent Binge Ethanol Treatment: Reversal Learning
Deficit
To investigate global behaviors in adults following AE binge treatment (P28-37), we
assessed young adult mice (P63-P72; Figure 1) for locomotor open field activity, Morris
Water Maze acquisition and reversal learning, as well as prepulse inhibition and anxiety-like
behavior in the elevated plus maze. In the water maze, mice from both groups easily learned
with a visual cue on the platform (Figure S2A, <10 seconds). Similarly, in the hidden
platform task, both groups learned in parallel over four days of testing, as indicated by
reduced time to find the hidden platform (Figure S2B). Results from a probe trial also
supported equivalent learning ability in both groups, since both spent significantly more of
their search time in the correct quadrant, and less than 20% in the incorrect quadrants, with
no difference between the treatment groups (Figure S2C). Both groups of mice received 3
days of reversal learning training with the platform in the opposite quadrant, with both
groups showing a modest reversal (Figure S2D). The reversal learning probe trial indicated
significant differences between young adult control and young adults following adolescent
binge ethanol treatment (Figure 5).
Following reversal training, the control mice no longer demonstrated a strong preference for
the original platform location in quadrant 1, spending roughly an equal amount of time also
searching quadrant 3, where the platform had been re-located during reversal. In contrast,
the ethanol-treated mice significantly spent more than twice as much time in quadrant 1
(35.6%) than in the quadrant with the new platform location (15.5%), demonstrating a
perseverative response pattern (Figure 5A; **p<0.01). Further, the ethanol-treated group
spent significantly less time than the control mice searching quadrant 3, where the platform
had been re-located during reversal († p<0.05, compared to controls). These findings
demonstrate adolescent binge ethanol treatment of C57BL/6 mice does not cause young
adult spatial learning deficits, but disrupts reversal learning.
We tested a spectrum of other behaviors to determine if adolescent binge ethanol caused
other differences in adult mice. Behaviors associated with sensorimotor gating, locomotor
activity, and anxiety showed no significant differences between groups. Prepulse inhibition
is a measure of sensorimotor gating. Adult mice that received alcohol during adolescence
showed nonsignificant reductions in prepulse inhibition across all the prepulse decibels
tested (Figure S3, 2-way ANOVA: p=0.11, F=2.931). Reductions at two of the prepulse
decibels measured (78 and 90dB) reached statistical significance using a t-test (*p<0.05).
Locomotor activity in the open field was the same in both groups across a one-hour period
(Figure S3B, 2-way ANOVA: p =0.27, F=1.30). In the elevated plus maze, a measure of
anxiety-like behavior, both groups spent similar amounts of time in the open arms (Figure
S3C, control: 35.9 sec ± 8.3, ethanol 39.4 sec ± 4.5, p=0.73, t test) and the closed arms
(control: 203.6 ± 16.1, ethanol 210.7 ± 7.1, p=0.72, t test). Center time in the open field,
another measure of anxiety-like behavior and activity in a novel environment, was also
unchanged between groups (Figure S3D, 2-way ANOVA: p=0.94, F=0.005). Thus, C57BL/
6 mice are behaviorally resilient and adolescent binge drinking procedures do not alter
global locomotor, spatial learning, sensorimotor gating or anxiety assessments in young
adults. Only the reversal learning probe trial indicated persistent young adult dysfunction
following adolescent binge drinking.
Adolescent Binge Ethanol Reduces MRI Adult Basal Forebrain and Olfactory Bulb Brain
Regional Volume
To investigate adult brain structure following adolescent binge ethanol treatment, we
performed MRI on postmortem adult mouse brains. Twenty brain regions were initially
segmented in an automatic fashion to identify candidate regions for further manual
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segmentation (Fig. 6, Fig. 7, Fig. 8, Fig. 9). Although not statistically different, mean total
brain volume and neocortex volume were 1-2% lower in AE treatment groups, being
441mm3 vs 435 mm3 and 152 mm3 vs 148 mm3 in young adult control and adolescent
alcohol treated animals (both P79) respectively. Further segmentation of the frontal cortex
(from the genu of the corpus callosum forward) found no differences in volume (not shown).
Some brain regions such as the globus pallidus and internal capsule tended to show
increased mean volumes in adults following adolescent binge alcohol treatment that were
not statistically significant. Four brain regions in adolescent binge treated young adults
showed >4% decreases in mean volume, basal forebrain−4.4% (p<0.02), olfactory bulb
−6.5% (p<0.046), anterior commissure −5.1% (p<0.04) and hippocampus −4.5% (p=0.11)
(Table 3). These findings suggest that adolescent binge alcohol treatment has brain region
specific effects.
Basal forebrain, olfactory bulb, anterior commissure, and hippocampus were manually
segmented by blinded investigators to refine segmentation volumes. Manual segmentation
reduced variation and mean differences between groups. For example, control hippocampal
automated segmentation volumes ranged from 22 to 27.5 mm3 (coefficient of variation =
0.66) compared to manual hippocampal volumes that ranged from 24.5 to 28 mm3
(coefficient of variation = 0.45), likely due to the difficulty in resolving the most anterior
and ventral regions of the hippocampus. Both automated and blinded manual segmentation
indicated AE treated animals have slightly smaller, but not significantly different
hippocampal volumes (Figure S4A). Though automatic segmentation reported significantly
smaller anterior commissure in mice that underwent adolescent binge, no significant
difference was found when segmented manually (p=0.31), indicating that AE treated
animals may have slightly smaller, but not significantly different anterior commissure
volumes (FigureS4B). However, manual segmentation of the olfactory bulb (Figure 7) and
the basal forebrain/septum (Figure 8) confirmed significant reductions in volume in adult
mice that received adolescent binge ethanol treatment. The mouse olfactory bulb is a large
frontal brain region representing over 5% of mouse brain volume that is embedded in the
skull making automated skull striping and segmentation difficult. Olfactory bulb volume
was reduced 6.5% by automated analysis (Table 3) and 7.8% (Figure 7, **p<0.005) by
manual segmentation. Overlays show overall olfactory bulb reductions (Figure 7), consistent
with binge ethanol treatment induced adolescent olfactory bulb and cortex necrosis (Crews
et al., 2000a) and inhibition of adolescent frontal neurogenesis(Crews et al., 2006) found in
rat studies.
The basal forebrain is a collection of structures located ventrally to the striatum. It is
considered to be the major cholinergic output of the CNS. It includes a group of structures
that lie near the bottom of the front of the brain, including the nucleus basalis, diagonal band
of Broca, ventral pallidum and medial septal nuclei. These structures are important in the
production of acetylcholine, which is then distributed widely throughout the brain. The adult
basal forebrain/septum region volume was reduced in the AE treated young adults.
Automated analysis found a −4.4% (Table 3; p<0.03) and manual analysis −4.5% decrease
in forebrain/septal volume (Figure 8, **p<0.01). Forebrain/septum includes the nucleus
basalis, diagonal band of Broca, and medial septal nuclei. The basal forebrain, through
widespread projections to cortex, particularly prefrontal cortex, plays an important role in
the modulation of cortical activity in association with different behavioral states including
sleep, learning and memory (Everitt and Robbins, 1997; Jones, 2004; Sarter et al., 2003;
Weinberger, 2003). By integrating images into a 3-dimensional rendering and overlaying
forebrain (Figure 8), we show that the posterior forebrain (bregma + 0.13 to −0.46)
accounted for most (71%) of the regional volume loss (Figure 8C, 11% reduced from
controls, ***p<0.001). To further investigate forebrain structure, histological sections were
prepared and histochemistry used to determine cellular composition and forebrain/septum
Coleman et al. Page 11










volume. Immunohistochemistry for GABA interneuron subtypes markers calretinin,
calbindin, and parvalbumin (PV) did not show visible changes in the density of these
neurons. PV+IR neuron density is high in forebrain, allowing visualization of basal
forebrain boundaries facilitating assessment of basal forebrain histology area. Area
assessments of forebrain with PV+IR sections indicated adolescent binge alcohol treatment
reduced basal forebrain area (p<0.05, 2-Way ANOVA, Figure 9). Dividing forebrain into
bregma regions as done with MRI indicated histological forebrain area was reduced
particularly in the more posterior regions of the basal forebrain from bregma + 0.02 to −
0.22 (Figure 9A, *p<0.05, t-test). Examples of two of the measured regions of interest in the
posterior basal forebrain are shown (Figure 9B, C). Reduced histological basal forebrain
area supports the observed MRI volume reduction in the posterior basal forebrain. Thus,
adolescent binge ethanol treatment results in reduced volume of adult olfactory bulb and
basal forebrain.
Adolescent Binge Ethanol Causes a Reduction in the Number of Cholinergic Neurons in
the Adult Basal Forebrain
Basal forebrain cellular composition was investigated using IHC. As mentioned above,
histochemistry for GABA interneuron markers calretinin, calbindin, and parvalbumin found
no marked changes after adolescent alcohol treatment. Similarly, astroglial marker glial
fibrillary acidic protein was similar between groups (data not shown). Our gene expression
studies found ChAT gene expression was decreased 71% at P38 following adolescent binge
treatment (Figure 10). The basal forebrain is rich in cholinergic neurons, critical for learning
and memory, that project to multiple brain regions to integrate cortical activity. We used
ChAT+IR to identify cholinergic neurons (Figure 10). The density of ChAT+IR neurons
was decreased 7.5% from 166 to 153 cells/mm2 in the Ch4 region (see Methods) of the basal
forebrain (Figure 10A, *p<0.05). This change is similar in magnitude to the observed
volumetric reduction in these mice, suggesting that cholinergic neuron loss contributes to the
reduction in basal forebrain volume. Thus, adolescent binge drinking reduced density of
ChAT+IR neurons in the adult basal forebrain.
Discussion
Changes in adult neurotransmitter-specific gene expression, postmortem MRI brain region
volumes, forebrain histological area, cholinergic neuron density and reversal learning
converge to support the conclusion that adolescent binge drinking in mice persistently alters
the adult brain. We found greater levels of neurotransmitter-specific gene expression in
adolescent brain than adult brain, consistent with other studies finding that dopaminergic,
cholinergic and other key neurotransmitters peak during adolescence (Andersen et al., 2000;
Crews et al., 2007; Spear, 2000; Tarazi and Baldessarini, 2000). Adulthood changes in
neurotransmitter gene expression over 50 days were not as large as adolescent maturational
changes in neurotransmitter gene expression, but were statistically evident, suggesting
neurotransmitter maturation continues into adulthood. Binge ethanol treatment in
adolescence dramatically reduced expression of many neurotransmitter-specific genes early
after treatment (P38, Figure 2). None of the neurotransmitter-specific genes showed
increased expression following ethanol treatment of adolescents. The greatest reductions
were found with the combination of binge AE treatment followed by development to young
adulthood, P88. The expression of several genes implicated in mental illnesses were
decreased by adolescent binge ethanol treatment. Binge ethanol during adolescence, but not
adulthood, decreased DA-D4R mRNA and orbital frontal cortical D4DR+IR in adolescence.
D4 receptors bind atypical antipsychotics with higher affinity than other dopamine receptors
(Van Tol et al., 1991), and are implicated in novelty seeking, substance abuse (Lusher et al.,
2001; Munafo et al., 2008) and attention deficit with hyperactivity disorder (Bellgrove and
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Mattingley, 2008). Thus, adolescent binge-drinking alters D4 dopamine receptors,
particularly in the orbital frontal cortex.
GRPR (gastrin-releasing peptide receptor), COMT, dopamine receptors D1A, and D2 were
not altered in adolescence immediately following binge treatment (P38), but after treatment,
during young adulthood, mRNA expressions were about half as much as their age matched
controls (Table 1, P88 Ethanol). Binge ethanol treatment of adolescent rats has been found
to reduce D1 and D2 protein levels in frontal cortex and other brain regions (Pascual et al.,
2009) and human alcoholics have fewer brain D2 receptors that are suggested to be a
predisposing factor due to persistently low levels in both early and late withdrawal (Volkow
et al., 2002). Decreases in dopamine receptors could be associated with decreased
motivation (Ernst et al., 2009). GRPR expression, a receptor for gastrin releasing peptide
and bombesin, was stable across the ages studied, but adolescent binge treatment reduced
adult expression 45% without altering adolescent expression. GRPR is enriched in amygdala
and GRPR deficient mice show enhanced fear conditioning with normal spatial learning and
no anxiety-like behavior in the water maze and elevated plus maze, respectively
(Shumyatsky et al., 2002). Environmental enrichment during adolescence increases GRPR
expression and reduces fearfulness (Qian et al., 2008), suggesting that environmental
amygdala plasticity during adolescence is in part reflected in GRPR expression and lifelong
sensitivity to amygdala fear conditioning. COMT polymorphisms have been implicated in
many disorders including addiction (Enoch, 2006), schizophrenia (Tan et al., 2007),
aggression (Volavka et al., 2004), and Alzheimer's disease (Serretti et al., 2007). These
findings indicate that AE exposure alters expression of neurotransmitter genes in the young
adult brain that are associated with psychopathology.
Heavy episodic drinking within the past 2 weeks is reported by 12% of 8th graders, 22% of
10th graders, 28% of 12th grade seniors and 44% of college students (Johnston et al., 2004;
Masten et al., 2008; Wechsler et al., 1995; Windle et al., 2008). In our model of adolescent
binge drinking in C57BL/6 mice the 5 gm/kg/day dose is less than mice from this strain
drink by choice (>15 gm/kg/day) (Crews et al., 2004). The high peak blood ethanol levels
(288 mg/dL) in this model are appropriate since alcohol dependent human adolescents report
approximately 13 drinks per drinking episode (Deas et al., 2000), consistent with blood
ethanol levels of 250-299 mg/dL, 50-65 mM (Jones and Holmgren, 2009). C57BL/6 mice
metabolize ethanol approximately 3.5 times faster than humans (≈9.7mmole/kg/hr in mice
vs ≈2.7mmole/kg/hr in humans), suggesting that elevated blood alcohol levels persist longer
in humans than mice (Thurman et al., 1982; Bradford et al., 2007). Our adolescent binge
ethanol treatment followed by assessments in young adults mimics the “young adult alcohol
dependent subtype,” the most common alcohol dependence subtype characterized by heavily
drinking during adolescence -young adulthood, and maturation out of dependence (Jacob et
al., 2005; Moss et al., 2007). Although it is of interest to distinguish adolescent from adult
responses, since human adolescents represent the majority of binge drinkers, understanding
the persistent effects of adolescent binge ethanol on the adult brain may be the most
important for human health considerations. Therefore, though we compared the effects of
binge ethanol during adolescence with that of adults on neurotransmitter receptor genes, we
focused the remainder of our analyses on the persistent effects of the adolescent binge. Our
model replicates rat models of binge drinking that did not demonstrate changes in locomotor
activity (Slawecki et al., 2001), water maze spatial learning (Schulteis et al., 2008; White et
al., 2002) or elevated plus maze performance (White et al., 2002). We found alterations in
reversal learning in young adult mice after adolescent binge treatment, consistent with an
adult rat binge drinking model (Obernier et al., 2002). Reversal learning deficits have been
observed in human alcoholics (C. B. Fortier et al., 2008), cocaine addicts (Fortier et al.,
2008; Stalnaker et al., 2009) and neurodegenerative diseases (Freedman and Oscar-Berman,
1989; Oscar-Berman and Zola-Morgan, 1980). Frontal cortex, where we found altered
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adolescent D4DR expression, and marked rat adolescent binge brain damage (Crews et al.,
2000a), is implicated in drug dependence and reversal learning deficits (Schoenbaum et al.,
2009). Reversal learning deficits have also been observed in rats and marmosets following
lesions of the basal forebrain (Cabrera et al., 2006; Roberts et al., 1992; Tait and Brown,
2008). Our finding suggests that individuals who drink heavily during adolescence may be
more likely to have reversal learning deficits, possibly mediated by chemical or structural
changes in frontal cortex or basal forebrain.
Alcohol is known to have differential effects on adolescents than adults. Developing
neurocircuitry in adolescents likely underlies the increased sensitivity to disruption of
working memory and hippocampal function (White and Swartzwelder, 2004), reduced
ethanol sedative response compared to adults (Silveri and Spear, 1998), increased
neurotoxicity (Crews et al., 2000b) and exaggerated thrill seeking, social and motivational
behaviors (Ernst et al., 2006). Human studies using in vivo brain imaging (Pfefferbaum et
al., 2009) and post-mortem histology (Harper, 2009) find alcoholics have brain volume
reductions compared to age matched controls, including adolescents (De Bellis et al., 2005).
Pre-existing conditions (Prescott and Kendler, 1999) and/or binge drinking induced
pathology (Stephens and Duka, 2008) could contribute to differences between binge and
non-binge drinkers.
To our knowledge, this is the first report of young adult mouse brain MRI following
adolescent binge treatment. We found reduced olfactory bulb and basal forebrain volume.
Alcoholics have persistent olfactory deficits (Kesslak et al., 1991; Rupp et al., 2003),
associated with loss of brain volume and ventricular expansion (Shear et al., 1992). We
found a 4-10% volume reduction across basal forebrain regions, comparable in magnitude to
human MRI brain regional volume reductions in alcohol use disorder (Makris et al., 2008;
Sullivan et al., 2005). Human MRI medial septal/diagonal band volume is negatively
correlated with age in alcoholic individuals, with volume reductions being associated with
deficits in verbal working memory (Sullivan et al., 2005). Basal forebrain cholinergic
neurons project to frontal cortex, hippocampus, and amygdala. These neurons modulate
information processing, allowing contextual associated information to exist concurrently in
memory with little interference to facilitate reversal plasticity. Proactive interference,
previous learning disrupting later learning, is minimized by forebrain acetylcholine. Human
fMRI shows basal forebrain activation during resolution of proactive interference tasks in
normal individuals but not in alcoholics (De Rosa et al., 2004). Damage to the basal
forebrain could alter an individual's ability to resolve proactive interference, altering reversal
learning ability. These findings, taken together with our findings suggest persistent basal
forebrain dysfunction following adolescent binge drinking that continues through life.
We found decreases in the expression of many cholinergic-specific genes including ChAT,
as well as all 5 subtypes of the muscarinic cholinergic receptors measured in young adult
mice following adolescent binge treatment. Post-mortem brains from humans with alcohol
use disorder have fewer muscarinic receptors and other cholinergic markers in hippocampus
(Freund and Ballinger, 1989a; Nordberg et al., 1983) and cerebral cortex (Freund and
Ballinger, 1989b). Adolescent binge treatment of rats has been shown to disrupt adult sleep
and electrophysiology consistent with altered cholinergic systems (Ehlers and Criado, 2010).
In adult rats, 28 weeks of alcohol treatment results in a progressive and persistent loss of
60-80% of multiple induces of forebrain cholinergic neurons (Arendt et al., 1995; Arendt et
al., 1988b) that are associated with memory impairments (Arendt et al., 1988a). After 8
weeks of ethanol treatment in adult rats, full recovery of reductions in ChAT activity was
observed in the basal forebrain during 4 weeks of abstinence (Arendt et al., 1989). We found
reduced forebrain histological area and cholinergic neuron density in young adult mice
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following adolescent binge treatment for only 10 days, with no evidence of recovery from
gene array or immunohistochemistry.
In summary, adolescent binge ethanol treatment of mice reduces young adult
neurotransmitter gene expression, particularly cholinergic genes, as well as forebrain MRI
volume, histologic area, cholinergic neuron immunohistochemistry, and reversal learning
performance.
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Experimental Design included adolescent treatment groups (A) and adult treatment groups
(B) followed with assessments 40-50 days after treatment. (A) Adolescent mice (P28) were
treated with either water or ethanol (5g/kg i.g.) once daily for ten days during adolescence
(P28-37). One group underwent behavioral testing in adulthood (P60-72) and were
sacrificed one week after the end of behavioral testing for postmortem brain magnetic
resonance imaging (MRI) and immunohistochemistry (IHC) (N=10 Control, 8 Ethanol). A
second group of adolescent mice was treated with either water or ethanol (5g/kg i.g.) once
daily for ten days (P28-37)and assessed for neurotransmitter gene expression 24 hours after
ethanol treatment (P38; N=6 Control, 6 Ethanol) as well as after a 50 day period of
maturation to adulthood (P88; N=6 Control, 6 Ethanol). (B) Young adult (P88) treatment
with either water or ethanol (5g/kg i.g.) once daily for ten days (P88-97). Mice were
sacrificed either 24 hours (P98; N=6 Control, 6 Ethanol) or 50 days later (P148; N=5
Control, 6 Ethanol). The Neurotransmitter Receptor and Regulator Gene Superarray™ was
used to measure gene expression 24 hours after ethanol treatment in both adolescent (P38)
and young adult groups (P98). Similarly following a 50 day period of maturation the
Neurotransmitter Receptor and Regulator Gene Superarray™ determined expression in
young adult (P88) and mature adult (P148) groups.
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Additional details are within the methods. Adolescent ethanol (AE) binge treatment, but not
adult ethanol binge, robustly alters the developmental trajectory of neurotransmitter-specific
gene expression. Mice received water or ethanol (5g/kg, i.g.) once a day for ten days during
either adolescence (P28-37) or adulthood (P88-97). Neurotransmitter-specific gene
expression was assessed using a gene SuperArray either 24 hours (P38 or P88) or 50 days
(P88 or P148) after the last alcohol treatment. Expression for each gene is compared to
control expression levels 24 hours after treatment (P38 or P88). (A) Developmental changes
in gene expression in young control mice. A developmental reduction in neurotransmitter
receptor and regulator gene expression was observed across the entire array (Average of
56% reduction, 2-way ANOVA, ***p<0.001) with 36 genes reaching a p<0.05. Genes that
showed either a potential increase in expression or no reduction at all are labeled. (B)
Developmental changes in gene expression in adult control mice. A developmental
reduction in neurotransmitter receptor and regulator gene expression was observed across all
the genes tested (2-way ANOVA, ***p<0.0001) that was on average less than controls (33%
average reduction) with 11 genes having a p<0.05. (C) Adolescent binge ethanol treatment
potentiates the developmental reduction in gene expression, causing significant reductions in
59 genes (p<0.05, t-test of normalized ΔCt values vs P38 control) with 31 genes
maintaining statistical significance following Bonferroni adjusted post-tests. (D) Adult binge
ethanol resulted in only two genes showing reductions from P98 to P148 that reached a
p<0.05, with zero changes following Bonferroni adjusted post-tests. Thick lines and
corresponding labels illustrate which treatment was given prior to testing.
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Effects of adolescent binge ethanol treatment ondopamine D4 receptor (D4DR) gene and
protein expression. Adolescent mice received either water or binge ethanol (5g/kg once
daily, i.g.) for ten days (P28-37). Mice were sacrificed 24 hours (P38) or 50 days (P88) after
the last treatment for RT-PCR and immunohistochemistry. (A) The adolescent ethanol binge
treatment caused a 71% (*p<0.05 vs P38 controls) reduction in D4DR gene expression in
whole brain 24 hours after treatment at P38 that remained reduced at P88. Control mice
underwent a 55% developmental reduction in D4DR gene expression (P38 to P88). (B)
Quantification of punctate D4DR immunoreactivity (D4DR+IR) in the orbitofrontal cortex
in adolescent mice (P38). Adolescent mice that received binge ethanol had 44% less D4DR
+IR in the orbitofrontal cortex than controls (Controls: 26800 ± 5500 D4DR+IR puncta/
mm2; Ethanol: 11790 ± 2900 D4DR+IR puncta/mm2, *p<0.05, t-test; N=3 Control, N=4
Ethanol). Although gene expression is whole brain and D4DR+IR protein levels are orbital
frontal cortex, both show significant decreases following adolescent ethanol binge treatment.
(C and D) Images of orbitofrontal cortex from adolescent (C: P38) and adult (D: P88) mice.
C: Images of punctate D4DR+IR staining in P38 control and P38 binge ethanol (Etoh)
treated mice (magnification 120×). D4DR+IR puncta are identified by the arrow heads (Δ).
Adult D4DR+IR are both punctate and somatic. Somatic staining is identified by arrows. D:
Images of orbitofrontal cortex from adult (P88) mice. Note D4DR+IR staining in P88 adult
is both punctate and somatic. Quantification of P88 D4DR+IR was 6800 ± 4500 D4DR+IR
puncta/mm2 for controls and 4790 ± 2900 D4DR+IR puncta/mm2 for ethanol treated
animals (N=3 Control, N=4 Ethanol). (t-test; vs P38 controls, Scale bar: 20 micron).
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Adolescent alcohol binge differentially alters developmental trajectory of neurotransmitter
receptor and regulator gene expression. RT-PCR was performed using an RT2 Profiler PCR
Array for neurotransmitter receptor and regulator genes. mRNA levels are presented as
percent of P38 control to demonstrate the effects across development Patterns of adolescent
ethanol binge (AE binge) treated animal developmental trajectory for Cholecystokininβ
(CCKβ) and Catechol-O-methyltransferase (COMT) are shown. (Left) Binge ethanol
treatment reduces P38 CCKβ expression by 64% of P38 control. Both control and ethanol
groups show a similar developmental decline during the fifty days after the adolescent
ethanol binge. In controls, CCKβ receptor gene expression decreases 55% across
development from P38 (100%) to P88 (45% of P38 control, *p<0.05). In ethanol binge
animals CCKβ mRNA levels were reduced 82% (**p<0.01 vs P38 control). However, the
developmental decline from P38 AE binge (55% of P38 control) to P88 AE binge (18% of
P38 control) is comparable to the control developmental decline. Adult P88 AE binge
animals express 39% of P88 control CCKβ mRNA expression (†p<0.05, vs P88 control)
similar to the 45% P38 AE binge animals suggesting the developmental decline continued a
similar course following the initial AE binge insult. (Right) Catechol-O-methyltransferase
(COMT) shows a different pattern. Binge ethanol treatment does not change P38 COMT
gene expression. The 50 day developmental decline in COMT brain gene expression in
controls was not statistically significant (29% reduction, p=0.24). However, AE binge
treated animals showed a 64% developmental reduction in COMT gene expression (p<0.01
vs P38 controls). AE binge treatment appears to alter the developmental trajectory of COMT
gene expression.
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Mice that received ethanol binge during adolescence had a deficit in reversal learning as
adults. Following acquisition of reversal learning, mice were tested in a 60 second probe
trial in the absence of the hidden platform. (A) Control mice spent a nearly equal amount
time in the initial learning quadrant (Quadrant 1, 22.4%±3.02) and the reversal learning
quadrant (Quadrant 3, 25.5%±2.5). Adult mice were treated with ethanol during adolescence
spent more than twice as much time in the quadrant where the platform was during initial
learning (Quadrant 1, 35.6%±5.5) than where the platform was during reversal learning
(Quadrant 3, 15.5%±7.7) (**p < 0.01, t-test). Also, control mice spent significantly more
time in the reversal quadrant (Quadrant 3, 25.5%±2.5) than the mice that received alcohol
during adolescence (15.5%±7.7) († p<0.05, t test). Data is presented as mean ± SEM. N = 7
Control, 7 Ethanol. (B) Representative tracings of the reversal probe trial from one animal in
each treatment group, depicting the increased time spent by control mice in the reversal
learning quadrant (Quadrant 3) compared to adolescent ethanol treated mice, which spent
more time in the initial learning quadrant (Quadrant 1).
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Representative automatic segmentation of structural MRI. (A) Representative structural
MRI of a control mouse. Mean diffusivity images were computed from reconstructed
diffusion tensor data. (B) Brain regions were segmented in an automated fashion in order to
identify candidate regions for further manual segmentation. Key: pink-olfactory bulb, blue-
neocortex, brown-basal forebrain, yellow-anterior commissure, bright green-corpus
callosum, red-hippocampus, purple-thalamus, turquoise-hypothalamus, dark gray-rest of
midbrain, light gray- central gray, orange-superior colliculi, dark green-cerebellum, yellow
green-brain stem.
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Adolescent ethanol binge causes a reduction in the volume of the olfactory bulb in adults.
Adolescent mice received either water or ethanol (5g/kg) once a day for ten days (P28-37).
Postmortem MRI was performed on adults (P79). Following automatic segmentation,
manual segmentation of the olfactory was performed by blinded investigators. (A) 3D
representation of the brain showing large relative size of the olfactory bulb in the rodent
brain (darkened). (B) Overlay of 3D renderings of representative control and ethanol treated
adult olfactory bulbs. Arrowheads highlight volume differences between control (black) and
ethanol treated (white) groups (C) Adult olfactory bulb volume quantification following
manual correction. Adult mice that received binge ethanol treatment during adolescence
showed a 7.8% reduction in the olfactory bulb volume (Control: 23.37 ± 0.42 mm3; Ethanol:
21.54 ± 0.33 mm3; **p<0.005; N=10 Control, 8 Ethanol).
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Adolescent ethanol binge causes a reduction in the volume of the basal forebrain/medial
septum brain region in adults. Adolescent mice received either water or ethanol (5g/kg) once
a day for ten days (P28-37). Postmortem MRI was performed on adults (P79), the basal
forebrain region was manually segmented by blinded investigators, and its volume was
measured. (A) 3D schematic of the location of the basal forebrain/medial septum region
from the top, sagittal, and front/coronal perspectives. (B) Basal forebrain volumes from
manual segmentation. Adult mice that previously received ethanol showed a 4.6% reduction
in the volume of the basal forebrain/medial septum region (Control: 11.95 ± 0.12 mm3;
Ethanol: 11.40 ± 0.12 mm3, **p<0.01; N=10 Control, 8 Ethanol). (C) A regional analysis of
the basal forebrain volume shows that the majority of the volume reduction (11% reduced
from controls) was to the posterior segment of the basal forebrain (bregma + 0.13 to −0.46),
***p<0.001. (D) sagittal 3D rendering of two representative cases showing volume
reduction in adult mice that received adolescent binge ethanol.
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Basal forebrain nuclei area reduction in adults following adolescent ethanol treatment. In
order to confirm MRI volume reductions, the area of the basal forebrain region nuclei was
measured microscopically on sections immunolabeled for parvalbumin using bioquant
software, in three different regions defined by their distances from bregma (1.34 to 1.1 mm,
0.86 to 0.14 mm, and 0.02 to −0.22 mm). Area measures were taken on up to three different
immunolabeled sections per mouse, N=4-7 mice for each region. (A) The basal forebrain
area was significantly reduced in the posterior bregma of the basal forebrain: 20%
difference, 0.02 to −0.22 mm, *p<0.05; N=5 Control and 5 Ethanol mice. Basal forebrain
areas measured at bregma 0.14mm (B) and −0.22mm (C) are shown from representative
sections. The anterior commissure (open arrow) and internal capsule (closed arrow) were
used as landmarks and are labeled on the atlas and image to help with orientation. Key: VP-
ventral pallidum, SI-substantia innominata, HDB-horizontal diagonal band, MCPO-
magnocellular preoptic nucleus, LPO-lateral preoptic area, IPAC-interstitial nucleus of the
posterior limb of the anterior commissure, BST-bed nucleus of stria terminalis, AAD-
anterior amygdaloid area dorsal, aca-anterior commissure anterior.
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Adolescent Binge Ethanol Treatment Reduces Choline Acetyltransferase (ChAT) gene
expression and ChAT-immunoreactivity. Acetylcholine neurons were identified by
immunohistochemistry for choline acetyltransferase (ChAT). (A) ChAT mRNA levels
changed significantly across development. ChAT mRNA in adolescent mice (P38 – 100%)
decreased during maturation to P88 (64% reduction, *p<0.05) in control animals. ChAT
mRNA expression 24 hours following adolescent ethanol binge treatment showed a 55%
reduction (P38). Fifty days after the adolescent ethanol binge ChAT mRNA levels were
reduced 85% (**p<0.01 vs P38 control). (B) Reduced ChAT-immunoreactive (ChAT+IR)
neurons in adults. ChAT+IR neurons were counted in the posterior regions of the basal
forebrain (bregma 0.14mm to −0.22mm), where the greatest volume changes were observed.
This included the horizontal diagonal band, substantia innominata, ventral pallidum, and
magnocellular preoptic nucleus. Significant reductions in the number of ChAT+IR neurons
per area were observed (7.5% reduction, *p<0.05, N=10 Control, 8 Ethanol). Representative
images from an adult controls (C) and adults following adolescent binge ethanol treatment
(D) at the same bregma (0.14mm) showing differences in ChAT+IR.
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Table 3
Adult brain MRI volumes using automatic segmentation following adolescent binge ethanol.
Brain Region Control (mm3) Ethanol (mm3) % Change p value
Hippocampus 24.6 23.5 −4.5 0.11
Corpus Callosum & External Capsule 13.2 13.2 0.0 0.95
Caudate & Putamen 22.3 22.1 −0.9 0.69
Anterior Commissure 1.2 1.1 −5.1* 0.04
Globus Pallidus 2.4 2.6 6.6 0.39
Internal capsule 1.9 2.1 9.9 0.45
Thalamus 24.6 24.5 −0.4 0.91
Cerebellum 53.0 54.1 2.1 0.42
Superior Colliculi 8.30 8.26 −0.5 0.90
Ventricle 1.2 1.2 0.0 0.96
Hypothalamus 10.2 10.0 −1.1 0.84
Inferior colliculi 5.1 5.2 2.8 0.52
Central Gray 4.0 3.9 −2.0 0.63
Neocortex 151.5 147.5 −2.6 0.23
Amygdala 12.6 12.7 0.4 0.91
Olfactory Bulb 24.6 23.0 −6.5* 0.046
Brain Stem 55.4 55.8 0.7 0.85
Rest of Midbrain 11.13 11.15 0.2 0.94
Basal Forebrain & Septum 11.9 11.4 −4.4* 0.02
Fimbria 1.8 1.9 4.9 0.55
Total Volume 440.9 435.2 −1.3 0.37
The effect of adolescent binge ethanol on adult regional brain volume using Magnetic Resonance Imaging (MRI). Postmortem brains were scanned
using a 9.4T MRI scanner. Brain regions were segmented on the images using an automatic segmentation protocol. Volumes of the individual
structures (mm3) in control and ethanol groups, percent change from control, and the p value (t-test) are shown. The anterior commissure, olfactory
bulb, hippocampus and basal forebrain & septum (bold) showed changes that were investigated further with manual segmentation (*p<0.05). Since
this was an initial screening, a statistical correction for multiple comparisons was not performed, so that potential regions of interest would not be
discarded prior to a more thorough manual segmentation. Therefore displayed p values may contain type II errors, resulting in false positives.
Alcohol Clin Exp Res. Author manuscript; available in PMC 2013 January 14.
